Hormonal Contraceptives and Athletic Performance
Hormonal contraceptives are among the most commonly used medications by women of reproductive age, including athletes. Whether they help, hinder or have no clear effect on performance is a question surrounded by strong opinions and surprisingly limited high-quality data. Our editorial team reviews what the science supports, and where uncertainty remains.
The hormonal background
The natural menstrual cycle is driven by fluctuations in estrogen and progesterone across roughly a month, with these hormones influencing far more than reproduction. They affect body temperature, fluid balance, substrate metabolism, connective tissue and mood, all of which can plausibly touch on athletic performance.
Hormonal contraceptives work by supplying synthetic versions of these hormones to prevent ovulation and alter the natural cycle. Combined oral contraceptives contain both a synthetic estrogen and a progestin, while progestin-only methods, implants, injections and hormonal intrauterine devices deliver progestin alone in various forms.
Because these methods flatten or replace the natural hormonal rhythm, they also change the physiological backdrop against which an athlete trains and competes. In principle, this could affect everything from strength to endurance to injury risk. In practice, the effects measured in studies are often small and inconsistent.
Understanding this background matters because it explains why a single, universal answer is unlikely. Different formulations, doses and delivery routes create different hormonal environments, and individual women respond differently to each.
What the evidence shows on performance
Systematic reviews that pooled many studies have generally concluded that oral contraceptive use may be associated with slightly reduced performance on average compared with naturally cycling women, but that the effect is small and the quality of evidence is low. In plain terms, any average difference is minor and uncertain.
Studies on strength, power and endurance have produced mixed results. Some find no meaningful difference, others detect small changes in particular phases, and methodological differences make direct comparison difficult. Sample sizes are often small, and many studies do not control well for the specific contraceptive used.
One practical advantage sometimes noted is predictability. By stabilizing hormones and, with some regimens, allowing control over the timing of withdrawal bleeding, contraceptives can reduce symptoms such as heavy or painful periods that might otherwise disrupt training or competition.
The honest summary is that for most women, the choice of whether to use hormonal contraception is unlikely to make or break athletic performance, and should be guided primarily by health, contraceptive and symptom-management needs rather than by a hope of marginal performance gains.
| Performance domain | General finding | Certainty |
|---|---|---|
| Strength / power | Mostly no clear effect | Low |
| Endurance | Small, inconsistent effects | Low |
| Cycle symptom control | Often improved | Moderate |
| Overall average performance | Possibly slightly lower, uncertain | Low |
Recovery, body composition and bone
Hormones influence recovery and tissue health, so contraceptives have been studied for effects beyond raw performance. Evidence on muscle recovery and training adaptations is mixed, with no strong consensus that contraceptives meaningfully blunt or enhance gains from training.
Body composition is a common concern. Some women report changes in weight or fluid retention with certain formulations, though controlled studies do not consistently show large effects on fat mass. Individual variability is considerable, and perceived changes do not always match measured ones.
Bone health is an area where hormones genuinely matter. Estrogen supports bone density, and the relationship between some progestin-only injectable contraceptives and bone mineral density has been studied carefully, particularly in younger women. This is a topic worth discussing with a clinician, especially for athletes at risk of low energy availability.
Across these areas, the recurring theme is individual response: the same method can suit one athlete and not another, which is why monitoring how you personally feel and perform is more useful than any population average.
Safety, regulation and anti-doping status
Hormonal contraceptives are prescription medications in the United States and much of the EU, with well-characterized benefits and risks that a clinician weighs for each individual. Known considerations include a small increase in the risk of blood clots with combined methods, which is relevant for some athletes and travel-heavy schedules.
Importantly for athletes, standard hormonal contraceptives are not prohibited substances under anti-doping rules, so their use for contraception or symptom control does not raise doping concerns. This contrasts sharply with the anabolic agents and other drugs covered elsewhere on this site.
Because formulations differ widely, side-effect profiles vary. Some women tolerate a given method seamlessly; others experience mood changes, breakthrough bleeding or other effects that prompt a switch. This trial-and-feedback process is normal and best managed with a prescribing clinician.
The key safety message is that contraceptive choice is a medical decision in which performance is, at most, a minor consideration. Health, reliability of contraception, symptom relief and personal risk factors should lead.
Practical perspective and conclusions
For a female athlete weighing hormonal contraception, a sensible approach combines medical guidance with personal observation. Keeping a simple log of training quality, energy, mood and any symptoms across several weeks can reveal how a particular method actually affects you, which matters far more than averaged study results.
Practical takeaways:
- Average performance effects of hormonal contraceptives appear small and uncertain.
- Benefits for cycle-symptom control can be meaningful for training consistency.
- Bone and clot-risk considerations deserve attention and a clinician's input.
- Standard contraceptives are not banned in sport, unlike anabolic agents.
The editorial conclusion is that hormonal contraceptives should be chosen for health and contraceptive reasons, with performance as a secondary factor. The evidence does not justify either avoiding them out of fear of lost performance or using them in hopes of a competitive edge. Individualized decision-making, supported by a clinician, serves athletes best.
Readers may also wish to read our articles on hirsutism in female athletes, on taurine after 40, and on caffeine versus L-theanine for focus and recovery.
References
- Elliott-Sale KJ, McNulty KL, Ansdell P, et al. The effects of oral contraceptives on exercise performance in women: a systematic review and meta-analysis. Sports Med. 2020;50(10):1785–1812.
- McNulty KL, Elliott-Sale KJ, Dolan E, et al. The effects of menstrual cycle phase on exercise performance in eumenorrheic women: a systematic review and meta-analysis. Sports Med. 2020;50(10):1813–1827.
- Rechichi C, Dawson B, Goodman C. Athletic performance and the oral contraceptive. Int J Sports Physiol Perform. 2009;4(2):151–162.
- Oxfeldt M, Dalgaard LB, Jørgensen AA, Hansen M. Hormonal contraceptive use, menstrual dysfunctions, and self-reported side effects in elite athletes. Int J Sports Physiol Perform. 2020;15(10):1377–1384.
- Scott JPR, Sale C, Greeves JP, et al. Hormonal contraceptive use and bone health in female athletes. Br J Sports Med. 2013;47(6):322–328.
